Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Urocit

    - PMLiVE

    Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

    New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

    BOLDSCIENCE

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Recognizing C diff Awareness Month in 2024

    Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...

    Medscape Education

    - PMLiVE

    Honoring Educational Partners at ACG

    The recent ACG conference was an opportunity for members of the Medscape team to shine a light on their educational partners and honor them for their exceptional work.On October 21,...

    Medscape Education

    - PMLiVE

    Medscape Collaborates for Health Equity at DDW 2023

    Recently, DDW 2023 took place in Chicago, IL, and Medscape was on-site with patient advocacy organizations to help educate clinicians on health equity in gastroenterology.Medscape was joined during the conference...

    Medscape Education

    - PMLiVE

    AbbVie’s Rinvoq granted NICE recommendation as ulcerative colitis treatment

    The recommendation is for adults living with the condition in England and Wales

    - PMLiVE

    Merck’s Keytruda meets primary endpoint in phase 3 gastric cancer trial

    Gastric cancer is the fourth leading cause of cancer death worldwide

    - PMLiVE

    Italy accelerates the path towards digital therapeutics implementation

    PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy

    - PMLiVE

    New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease

    Drug provided 'rapid and sustained' normalisation of mean urinary-free cortisol levels

    - PMLiVE

    Switzerland: a life sciences hub

    Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country

    - PMLiVE

    FDA approves Recordati’s Cushing disease drug Isturisa

    Important new treatment option for patients with rare disorder

    - PMLiVE

    Takeda buys coeliac disease partner PvP Biologics after phase 1 win

    Deal includes upfront payment plus up to $330m in milestones

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links